Neurology Central

Elevating neuregulin 1 could alleviate Alzheimer’s symptoms

Researchers from the Salk Institute’s Clayton Foundation Laboratories for Peptide Biology (San Diego, CA, USA) have utilized rodent models to investigate the effects of increased hippocampal neuregulin 1 (NRG1) on Alzheimer’s disease (AD) symptoms and neuropathology. Utilizing a lentiviral vector system, the team demonstrated that elevated NRG1 may improve cognitive deficits and neuropathology in AD.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.